Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K Current Report — March 13, 2026
Filed: March 13, 2026
Health Care
Pharmaceutical PreparationsTonix Pharmaceuticals Holding Corp. (TNXP) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Tonix Pharmaceuticals Holding Corp. 8-K Mar 13, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q1 2025 earnings press release filed under Item 2.02 — actual financial figures contained in referenced exhibit, not in filing body
- • Exhibit disclosure structured to avoid Section 18 Exchange Act liability — standard "furnished not filed" treatment
Other Tonix Pharmaceuticals Holding Corp. 8-K Filings
Get deeper insights on Tonix Pharmaceuticals Holding Corp.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.